Skip to main content
. Author manuscript; available in PMC: 2022 Dec 22.
Published in final edited form as: Ann Nucl Med. 2019 May 30;33(8):617–623. doi: 10.1007/s12149-019-01371-8

Fig. 1.

Fig. 1

Images of a patient with oligometastatic clear cell RCC confirmed with 18F-DCFPyL PET/CT (Patient #12). a Whole-body 18F-DCFPyL PET maximum intensity projection image demonstrates a solitary site of abnormal uptake (red arrowhead) in the region of the left nephrectomy bed. b Axial, contrast-enhanced, venous-phase CT image demonstrates a recurrence in the left nephrectomy bed with tumor invading and expanding the left renal vein (red arrowhead). c Axial 18F-DCFPyL PET and d axial 18F-DCFPyL PET/CT images show focal radiotracer uptake in the lesion (red arrowheads)